Overview

Evaluation of Pharmacokinetics Profiles and Bactericidal Activity of Zabofloxacin

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
Phase I clinical study to compare the pharmacokinetic profiles and bactericidal activity of Zabofloxacin 183mg, 367mg and Levofloxacin 250mg after oral administration in healthy volunteer
Phase:
Phase 1
Details
Lead Sponsor:
Dong Wha Pharmaceutical Co. Ltd.
Treatments:
Fluoroquinolones
Levofloxacin
Ofloxacin